Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 12, Number 8—August 2006


Detecting Clostridium botulinum

Cite This Article


Highlight and copy the desired format.

EID Karner J, Allerberger F. Detecting Clostridium botulinum. Emerg Infect Dis. 2006;12(8):1292.
AMA Karner J, Allerberger F. Detecting Clostridium botulinum. Emerging Infectious Diseases. 2006;12(8):1292. doi:10.3201/eid1208.051364.
APA Karner, J., & Allerberger, F. (2006). Detecting Clostridium botulinum. Emerging Infectious Diseases, 12(8), 1292.

To the Editor: In the October 2005 issue of Emerging Infectious Diseases, Song et al. described a fiber-optic, microsphere-based, high-density array composed of 18 species-specific probe microsensors, used to identify biological warfare agents, including Clostridium botulinum (1). Although the researchers used multiple probes for C. botulinum, we doubt that this approach is suitable for this organism.

C. botulinum comprises a heterogenous group of subspecies that produce botulinum neurotoxin (BoNT); identification and characterization usually rely on animal testing that focuses on antigenetically distinct toxins (2). Although strains of C. botulinum that do not produce toxins are sometimes isolated from wound infections not related to botulism, some strains of C. butyricum and C. baratii are also able to produce BoNTs.

The mouse bioassay is currently the accepted method for detecting BoNT. In this assay, mice that receive an intraperitoneal injection containing a sample with more than a minimum lethal dose show symptoms of botulinum intoxication and die. ELISAs, which recognize protein antigenic sites, are still less sensitive than the mouse bioassay (3).

Because the mouse bioassay requires euthanizing many animals, and results are not available for several hours, new diagnostic methods are needed. For C. botulinum, an organism widely dispersed in the environment, DNA-based methods may not provide the ultimate solution. Rapid methods to detect and differentiate active BoNTs, such as the rapid, mass spectrometry-based, functional method, are promising candidates to substitute for animal testing in the near future (4).

Josef Karner* and Franz Allerberger*Comments to Author 

Author affiliations: *Medical University Innsbruck, Innsbruck, Austria


  1. Song L, Ahn S, Walt DR. Detecting biological warfare agents. Emerg Infect Dis. 2005;11:162932.PubMed
  2. Grif K, Dierich MP, Much P, Hofer E, Allerberger F. Identifying and subtyping species of dangerous pathogens by automated ribotyping. Diagn Microbiol Infect Dis. 2003;47:31320. DOIPubMed
  3. Ferreira JL, Eliasberg SJ, Edmonds P, Harrison MA. Comparison of the mouse bioassay and enzyme-linked immunosorbent assay procedures for the detection of type A botulinal toxin in food. J Food Prot. 2004;67:2036.PubMed
  4. Barr JR, Moura H, Boyer AE, Woolfitt AR, Kalb SR, Pavlopoulos A, Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg Infect Dis. 2005;11:157883.PubMed
Cite This Article

DOI: 10.3201/eid1208.051364

Related Links

Table of Contents – Volume 12, Number 8—August 2006


Please use the form below to submit correspondence to the authors or contact them at the following address:

Franz Allerberger, Medical University Innsbruck, Medical University Innsbruck–Hygiene, Fritz Pregl Str 3, Innsbruck Austria 6020

character(s) remaining.

Comment submitted successfully, thank you for your feedback.